Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms
|
|||||
Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease. . . . → Read More: Chewable Covid-19 Drug Reduces Viral Load, Symptoms Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions. . . . → Read More: Roche, Global Fund to Build Local Diagnostic Processes A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics. . . . → Read More: Biotech, Synthetic Bio Companies Partner on T-Cell Therapies A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence. . . . → Read More: Clinical Trial Set for AI-Driven Lung Fibrosis Drug A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |